500,118 Shares in Pediatrix Medical Group, Inc. $MD Bought by Empowered Funds LLC

Empowered Funds LLC acquired a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 500,118 shares of the company’s stock, valued at approximately $12,668,000. Empowered Funds LLC owned about 0.62% of Pediatrix Medical Group as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. Global Retirement Partners LLC boosted its stake in shares of Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after buying an additional 1,365 shares during the period. Transamerica Financial Advisors LLC acquired a new position in Pediatrix Medical Group in the 4th quarter valued at about $30,000. Eurizon Capital SGR S.p.A. purchased a new stake in Pediatrix Medical Group during the 4th quarter valued at approximately $33,000. TD Private Client Wealth LLC acquired a new stake in Pediatrix Medical Group during the 4th quarter worth approximately $39,000. Finally, Los Angeles Capital Management LLC acquired a new stake in Pediatrix Medical Group during the 4th quarter worth approximately $43,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Down 0.5%

Shares of MD stock opened at $26.66 on Friday. The business’s fifty day moving average price is $26.06 and its 200 day moving average price is $23.18. The firm has a market capitalization of $2.17 billion, a PE ratio of 12.76 and a beta of 0.66. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. Pediatrix Medical Group, Inc. has a 1-year low of $15.69 and a 1-year high of $27.94.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The company had revenue of $487.78 million during the quarter, compared to the consensus estimate of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.Pediatrix Medical Group’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.53 earnings per share. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Weiss Ratings lowered shares of Pediatrix Medical Group from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. Truist Financial boosted their price objective on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Finally, UBS Group lifted their target price on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Seven research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $25.00.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.